一线治疗原发性胆管炎患者表型分层的潜在类别混合模型
Latent class mixed modelling for phenotypic stratification of primary biliary cholangitis patients on first line treatment
摘要:
在原发性胆汁性胆管炎(PBC)患者中,熊去氧胆酸治疗期间测量的血清肝脏生化(UDCA反应)可准确预测长期结局。在这项研究中,我们试图使用肝脏生化,特别是碱性磷酸酶(ALP),作为疾病活动的替代标志物,在PBC的表型分层使用计算建模方法。我们的目的是确定不同的疾病亚组的患者不同的疾病轨迹。研究方法:我们使用了1,601例接受UDCA一线治疗的PBC患者的纵向ALP结果,并应用潜在类混合模型(LCMM)来识别不同的表型亚组,每个亚组具有不同的疾病轨迹和终末期肝病(ESLD)风险。结果:我们在PBC队列中确定了四个区分良好的表型亚组,每个亚组具有不同的疾病轨迹。
英文摘要:
In patients with primary biliary cholangitis (PBC), the serum liver biochemistry measured during treatment with ursodeoxycholic acid (the UDCA response) accurately predicts long-term outcome. In this study we sought to use liver biochemistry, and in particular alkaline phosphatase (ALP), as a surrogate marker of disease activity, for phenotypic stratification in PBC using a computational modelling approach. Our aim here was to identify distinct disease subgroups of patients with distinct disease trajectories. Methods: We used longitudinal ALP results from 1,601 PBC patients on first line treatment with UDCA, and applied latent class mixed modelling (LCMM), to identify distinct phenotypic subgroups, each with distinct disease trajectories, and risks of end stage liver disease (ESLD). Results: We identified four well discriminated phenotypic subgroups within our PBC cohort, each with distinct disease trajectories.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。